MedTrace Logo

Gycabiane and Glycemic Control of Prediabetic Subjects

NCT01530685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2021-04-20

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Glycabiane

2 gelule per day for 4 months

DIETARY_SUPPLEMENT

placebo

2 gelules per day for 4 months

Sponsors & Collaborators

  • PiLeJe

    lead INDUSTRY

Principal Investigators

  • Karine Clément, MD · INSERM U872

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-27
Primary Completion
2012-09-25
Completion
2012-09-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01530685 on ClinicalTrials.gov